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Background: Nonalcoholic fatty liver disease (NAFLD), a highly prevalent condition, is a 
feature of metabolic syndrome and is characterized by excessive accumulation of fat in the liver 
cells. The purpose of this study was to investigate the association between NAFLD and carotid 
intima-media thickness (CIMT) as an independent risk factor for atherosclerosis.
Methods: We examined 250 consecutive patients with ultrasonographically confirmed NAFLD 
and 85 age-matched and gender-matched controls with normal parenchymal liver echogenicity 
for determination of CIMT and presence of carotid atherosclerotic plaque.
Results: Compared with control subjects, patients with NAFLD showed an increased mean 
CIMT (0.81 ± 0.14 mm) compared with control subjects (0.58 ± 0.15 mm). This difference 
was statistically significant (P = 0.001). After performing multivariate analysis, the presence 
of NAFLD was associated with abnormal CIMT independent of other atherogenic risk factors 
or its association with metabolic syndrome.
Conclusion: NAFLD can be an independent risk factor for developing atherosclerosis. 
  Therefore, NAFLD with and without metabolic syndrome can be associated with increased 
CIMT and increased risk of cardiovascular events in patients with NAFLD incidentally diag-
nosed on abdominal ultrasonography.
Keywords: nonalcoholic fatty liver disease, metabolic syndrome, atherosclerosis, carotid intima 
media thickness, risk factor
Introduction
Nonalcoholic fatty liver disease (NAFLD), a highly prevalent condition,1 is a fea-
ture of metabolic syndrome and characterized by excessive accumulation of fat in 
the liver cells.2,3 Patients with NAFLD have a higher mortality rate than the general 
population.4
NAFLD is strongly associated with cardiovascular risk factors, such as obesity, 
dyslipidemia, type 2 diabetes mellitus, and insulin resistance.5 From previous published 
data, it is obvious that coronary heart disease mortality rates in patients with NAFLD 
are close to those associated with cirrhosis.6
Ultrasonographic measurement of carotid intima-media thickness (CIMT) is a non-
invasive method for demonstrating subclinical atherosclerosis. Increased CIMT has a 
significant relationship with the presence and severity of coronary atherosclerosis.7,8
In recent years, case-control studies have shown a relationship between NAFLD 
and the presence of early manifestations of atherosclerosis indicated by CIMT 
measurement.8,9 Other studies have shown only a relationship between NAFLD and 
advanced atherosclerosis, such as carotid plaque.10,11 However, the association between International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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CIMT and NAFLD requires further investigation because 
metabolic syndrome comprises multiple risk factors for 
coronary artery disease, which may have confounded the 
results of studies published to date.
In the present study, we investigated the association 
between NAFLD as a risk factor for atherosclerosis and 
CIMT by comparing a group of outpatients with NAFLD 
confirmed incidentally on ultrasonography and a control 
group with ultrasonographically normal liver echogenicity. 
Independent evaluation of CIMT in patients with NAFLD 
and other cardiovascular risk factors is the novelty of our 
present research.
Materials and methods
We examined 250 consecutive patients with incidental ultra-
sonographically confirmed NAFLD and 85 age-matched and 
gender-matched control subjects with normal parenchymal 
liver echogenicity for determination of CIMT and presence 
of carotid atherosclerotic plaque. The patients were referred 
to the Radiology Department from the Gastroenterology 
Outpatient Clinic at the University Training Hospital for 
measurement of CIMT after abdominal ultrasonography 
was performed for nonspecific abdominal discomfort, and 
diagnosis of fatty liver was made according to ultrasono-
graphic examination. All of the abdominal sonograms were 
performed by one radiologist (AH). Thirty-five patients with 
NAFLD were excluded from the study because they failed 
to meet the inclusion criteria. Exclusion criteria were heart 
disease, diabetes mellitus, acute or chronic liver disease, acute 
or chronic kidney disease, any malignancy, alcohol consump-
tion, pregnancy, liver masses, abnormal copper metabolism or 
thyroid function test, history of any medication with adverse 
effects on the liver, and a history of cigarette smoking. Only 
hepatitis B surface antigen-negative and hepatitis C antibody-
negative patients were enrolled.
Hypertension  was  diagnosed  as  blood    pressure 
.140/90 mmHg or the taking of antihypertensive drugs. 
Body mass index was calculated by dividing weight in kilo-
grams by height in meters squared. Blood samples were col-
lected in the morning after an overnight fast. Blood was tested 
for fasting glucose (normal range ,126 mg/dL), triglycerides 
(normal range ,200 mg/dL), total cholesterol (normal 
range ,240 mg/dL), high-density lipoproteins, C-reactive 
protein, mean platelet volume, and serum transaminases 
(alanine aminotransferase and aspartate aminotransferase). 
All blood samples were tested in the same laboratory.
High resolution B mode ultrasonography of both the 
common and internal carotid arteries was performed using 
an ultrasound machine (Sonoline G40; Siemens, Munich, 
Germany) equipped with a 10 mHz linear array transducer. 
Patients were examined in the supine position with the head 
tilted backwards. After the carotid arteries were located 
by transverse scans, the probe was rotated to 90° to obtain 
and record a longitudinal image of the common carotid 
arteries.
The maximum CIMT was measured at the posterior wall 
of the common carotid artery, 2 cm before the bifurcation, 
as the distance between the first and second echogenic lines 
of the anterior and posterior arterial walls. The image was 
focused on the posterior wall of the common carotid artery, 
and gain settings were used to optimize image quality. 
Measurement was performed vertical to the arterial wall for 
accurate measurement of CIMT (Figure 1). Three CIMT 
measurements were taken at each site and the average mea-
surement was used. The CIMT was assessed as being normal 
if it did not exceed 0.7 mm.7 All of the CIMT measurement 
sonograms were obtained by another radiologist blinded to 
the results of abdominal sonography and the clinical and 
laboratory data for cases and control subjects.
The anterior and posterior walls of the common carotid 
arteries, internal carotid arteries, and carotid bulbs were 
evaluated for determination of presence of carotid plaque, 
defined as a focal thickening .1.2 mm of the intima-media 
complex, measured from the media-adventitia interface to 
the intima-lumen interface (Figure 2). One radiologist experi-
enced in Doppler evaluation of the extracranial vessels, who 
had no prior knowledge of the patient clinical and laboratory 
data, performed the ultrasonographic examinations.
Abdominal ultrasound scanning was performed in all 
participants by another trained radiologist, who was blinded 
to all patient clinical and laboratory data, using a Toshiba 
Nemio 30 scanner (Toshiba Co Ltd, Tokyo, Japan) with a 
3.5 mHz linear transducer. Hepatic steatosis was diagnosed 
by a characteristic liver echo pattern as evidence of diffuse 
hyperechogenicity of the liver relative to the right kidney. 
The patients were divided into three groups based on the 
degree of fatty infiltration, ie, mild fatty liver (grade 1), 
moderate fatty liver (grade 2), and severe fatty liver (grade 3) 
according to the ultrasound appearance of hepatosteatosis. 
In grade 1 (mild) fatty infiltration, echogenicity was slightly 
increased, with normal visualization of the diaphragm and 
the intrahepatic vessel borders. Grade 2 (moderate) fatty 
infiltration was established when echogenicity was moder-
ately increased, with slightly impaired visualization of the 
diaphragm or intrahepatic vessels. In grade 3 (severe) fatty 
infiltration, echogenicity was markedly increased with poor International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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visualization of the diaphragm, intrahepatic vessels, and 
posterior portion of the right lobe. The study was approved 
by the institutional review board of the university, and all the 
participants provided their written informed consent.
statistical analysis
Statistical analysis was performed using SPSS software (v 16; 
SPSS Inc, Chicago, IL). Statistical significance was set at 
a two-sided P value of #0.05. Results are reported as the 
mean ± standard deviation, n (%) for continuous variables, 
and as frequencies for categorical variables. For comparison 
of patient and control data, one-way analysis of variance and 
t-testing were used for quantitative variables, and the Chi-
square test was used to determine the statistical significance 
of differences in qualitative variables. The relationship for 
continuous variables was examined by Pearson’s correlation 
coefficients and categorical variables by Spearman correla-
tion analysis. Thereafter, one-way analysis of variance was 
utilized to compare different variables (including intima-
media thickness, fasting blood sugar, triglycerides, total cho-
lesterol, high-density lipoprotein, low-density lipoprotein, 
alanine aminotransferase, aspartate aminotransferase, mean 
platelet volume, and body mass index) with the different 
grades of fatty liver disease. Multivariate modeling was 
done by linear regression analysis. In multivariate analysis, 
the presence of NAFLD was an independent variable and 
regression analysis was used.
Results
We examined 250 patients with NAFLD (139 male and 
111 female) and 85 controls (46 male and 39 female). 
Because of the study design, cases and control subjects were 
almost identical in terms of gender and age. The mean age of 
patients with NAFLD was 46.5 ± 10.5 years and for controls 
was 44.8 ± 14.1 (P = 0.078).
Patients with NAFLD had a higher frequency of elevated 
blood pressure than normal subjects (40% vs 15.2%). This 
difference was statistically significant (P = 0.001). Mean 
fasting blood glucose was significantly (P = 0.001) higher 
in patients with NAFLD (117.16) than in normal subjects 
(90.77). Levels of aspartate aminotransferase (P = 0.006), ala-
nine aminotransferase, mean platelet volume, and C-reactive 
protein were higher in patients with NAFLD than in the control 
group (P = 0.001). In patients with NAFLD, serum triglyc-
eride and total cholesterol levels were higher (P = 0.001) and 
high-density lipoprotein cholesterol was lower (P = 0.001) 
than in control subjects. Patients with NAFLD had a signifi-
cant higher body mass index than controls. The mean body 
mass index in patients with NAFLD was 29.88 ± 3.88 kg/m2 
and in the control group was 25.29 ± 4.19 kg/m2; this differ-
ence was statistically significant (P = 0.001). Patients with 
NAFLD had a greater mean CIMT (0.81 ± 0.14 mm) than 
control subjects (0.58 ± 0.15 mm); this difference was statisti-
cally significant (P = 0.001). The frequency of carotid plaque 
in patients with NAFLD was 1.7-fold higher than in controls 
(P = 0.176). All risk factors related to metabolic syndrome 
(body mass index, hypertension, glucose level, hypertrig-
lyceridemia, and high-density lipoprotein cholesterol) were 
significantly greater in patients with NAFLD than in control 
subjects (P = 0.001).
Table 1 shows the main clinical, ultrasonographic, and 
laboratory data for the patients and control subjects. In con-
trols, the mean value of CIMT in men was 0.56 ± 0.14 mm 
and in women was 0.61 ± 0.16 mm; this difference was not 
statistically significant (P = 0.09). In patients with NAFLD, 
mean CIMT in men was 0.79 ± 0.12 mm and in women was 
0.84 ± 0.17 mm; this difference was statistically significant 
(P = 0.019). Furthermore, after adjustment for multiple 
confounding factors, such as hypertension, diabetes mellitus, 
hypertriglyceridemia, hypercholesterolemia, and hyperglyce-
mia, the mean CIMT in control subjects was 0.56 ± 0.13 mm 
and in patients with NAFLD was 0.76 ± 0.09 mm, which 
was a statistically significant difference (P = 0.001). The 
presence of NAFLD was found to be associated with abnor-
mal CIMT independent of other atherogenic risk factors. 
Table 1 Main clinical, ultrasonographic, and laboratory data for 
patients with nAFLD and control subjects
Variable NAFLD Control P value
number 250 85
sex (M) 139 46 0.9
Age (years) 46.58 (±10.4) 44.85 (±14.17) 0.028
Weight (kg) 83.90 (±9.53) 70.3 (±11.27) 0.001
BMI (kg/m2) 29.88 (±3.88) 25.29 (±4.19) 0.001
ALT 30.10 (±33.47) 19.82 (±11.98) 0.006
AsT 37.23 (±26.64) 22.29 (±10.73) 0.001
TG (mg/dL) 189.14 (±88.1) 107.05 (±36.97) 0.001
Total cholesterol  
(mg/dL)
207.71(±49.81) 163.83 (±34.50) 0.001
hDL (mg/L) 41.05 (±8.62) 52.69 (±9.03) 0.001
MPV (fL) 10.51(±2.86) 9.10 (±1.12) 0.001
crP (+) 22.4% 3.5% 0.001
hTn (+) 40.8% 15.2% 0.001
Plaque (+) 20% 11.7% 0.176
FBs (mg/L) 117.16 (±61.52) 90.77 (±15.10) 0.001
IMT (mm) 0.81(±0.14) 0.58 (±0.15) 0.001
Abbreviations:  BMI,  body  mass  index;  TG,  triglycerides;  hDL,  high-density 
lipoprotein; crP, c-reactive protein; hTn, hypertension; FBs, fasting blood glucose; 
IMT, intima-media thickness; MPV, mean platelet volume; ALT, alanine aminotrans-
ferase; AsT, aspartate aminotransferase; nAFLD, nonalcoholic fatty liver disease.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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After   adjustment for multiple confounding factors, mean 
CIMT in men with NAFLD was 0.75 ± 0.08 mm and in 
women with NAFLD was 0.77 ± 0.1 mm, which was not a 
statistically significant difference (P = 0.36).
In Pearson analysis, there was a strong positive 
correlation between CIMT and mean platelet volume 
(r = 0.18, P = 0.0001), fasting blood sugar (r = 0.18, 
P = 0.0001), triglycerides (r = 0.18, P = 0.0001), total 
cholesterol (r = 0.19, P = 0.0001), body mass index (r = 0.39, 
P = 0.0001), and age (r = 0.44, P = 0.0001), and there was a 
strong negative correlation between high-density lipoprotein 
cholesterol and CIMT (r = −0.32, P = 0.0001). In multivariate 
linear regression analysis, the presence of elevated C-reactive 
protein (P = 0.006) hypertension (P = 0.005), and a combi-
nation of hypertension and elevated C-reactive protein were 
independent risk factors affecting CIMT (P = 0.003).
Discussion
NAFLD is defined as excessive accumulation of fat in hepa-
tocytes and has a range of pathologic presentations, ranging 
from simple steatosis to nonalcoholic steatohepatitis and 
cirrhosis. The prevalence of NAFLD is 20%–30% in the 
general adult population in Western countries12 and is now 
12%–24% in Asian-Pacific countries.13 Its prevalence in 
obese or diabetic patients increases up to 70%–90%.12
Although the exact pathophysiologic basis of NAFLD is 
not well understood, several investigations have suggested 
that excessive accumulation of triglycerides in hepatocytes 
due to insulin resistance is the first step, and that oxidative 
stress reactions resulting from mitochondrial fatty acid oxi-
dation and expression of inflammatory cytokines and adipo-
cytokines are other potential factors which cause hepatocyte 
injury, inflammation, and fibrosis.14
Our study revealed that the C-reactive protein level in 
patients with NAFLD was higher than in control subjects 
(P = 0.001). This finding suggests that the inflammatory 
state caused by excessive oxidative stress reactions may 
contribute to hepatic injury in patients with NAFLD. The 
main risk factors associated with NAFLD are increased 
bodyweight, diabetes mellitus, hyperlipidemia, and meta-
bolic syndrome.5 Approximately 90% of patients with 
NAFLD have at least one characteristic feature of metabolic 
syndrome and about 33% have the full complement of 
features.15,16 This strong association suggests that NAFLD 
may have a potential role in the development and progres-
sion of atherosclerosis. Some investigations suggest that 
the outcome in patients with NAFLD is more dependent 
on cardiovascular events than on the progression of liver 
disease.17–19
Previous investigations have demonstrated a strong 
relationship between CIMT and the risk of myocardial and 
cerebral infarction, and CIMT can identify patients at high 
risk for coronary artery disease effectively.20,21 Patients with 
a mean CIMT .1.15 mm have been reported to have a 94% 
likelihood of having coronary artery disease.21 Many   studies 
have evaluated the relationship between atherosclerotic 
risk factors and CIMT, and confirmed that CIMT thickness 
Figure 1 Longitudinal sonogram shows that the cIMT is 1.1 mm in a patient with 
nAFLD.
Figure 2 Longitudinal sonogram shows the presence of a soft hypoechoic carotid 
plaque in anterior wall of common carotid artery (ccA).International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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increases with age, gender, hypertension, diabetes mellitus, 
and hyperlipidemia.22,23
In this case-control study, we evaluated carotid athero-
sclerosis by measuring CIMT as an indicator of cardiovas-
cular risk in patients with incidental ultrasonographically 
confirmed fatty liver. We established the diagnosis of 
NAFLD according to ultrasonographic appearance and exclu-
sion of other known etiologies of chronic liver disease. The 
diagnosis was not confirmed by liver biopsy for ethical 
reasons. Ultrasonography can detect increased liver echo-
genicity and confirm the diagnosis of NAFLD, particularly 
when hepatic fat infiltration is more than 33%.24 In this study, 
CIMT in patients with NAFLD was significantly higher 
than in a gender-matched and age-matched control group 
(P = 0.001). When compared with control subjects, women 
with NAFLD had a mean CIMT even higher than men with 
NAFLD (P = 0.019).
Our study found no gender-related difference in mean 
CIMT for patients with NAFLD and without metabolic syn-
drome, but the mean CIMT in female patients with NAFLD 
was higher than for male patients with metabolic syndrome 
(P = 0.019). This finding is similar to those of studies that 
showed several metabolic traits25 for the metabolic syn-
drome to have greater atherogenic effects on women than 
in men.26,27
Our study revealed an association between incidentally 
diagnosed NAFLD and CIMT, but no significant relation-
ship between carotid plaque and NAFLD. Many studies have 
demonstrated an association between NAFLD and CIMT.28,29 
Volzke et al showed that there is an independent association 
between hepatic steatosis and carotid plaques, but not with 
CIMT.30 Although in our study the body mass index in con-
trols and patients with NAFLD was different, and previous 
data have shown that there is a relationship between body 
mass index and CIMT,31–33 our data confirm that most of the 
adverse effects of obesity are due to a high prevalence of 
hypertension and hyperglycemia, because these patients had 
a higher prevalence of cardiovascular risk factors and showed 
signs of early atherosclerosis.
We measured mean CIMT in the posterior wall of both 
common carotid arteries because this location is more reli-
able and more easily accessed compared with other carotid 
segments. Previous research has shown that collection of 
data from all carotid segments can predict cardiovascular 
risk more accurately than collection of data from only the 
common carotid.25 Therefore, our study may have a potential 
limitation in estimation of the relationship between NAFLD 
and risk of cardiovascular events.
In conclusion, NAFLD may be an independent risk 
factor for developing atherosclerosis. Therefore, NAFLD 
without other cardiovascular risk factors can be associated 
with increased CIMT and increased risk of cardiovascular 
events in patients with NAFLD incidentally diagnosed on 
abdominal ultrasonography. NAFLD may serve as a trigger 
for assessment of silent carotid lesions and cardiovascular 
risk factors, and such patients should undergo further car-
diovascular assessment.
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